Xylem Reports Strong Q2 Results, Raises Full-Year EPS and Profitability Guidance
XYL sits 16% above its 52-week low of $105.29.
Summary
Xylem Inc. announced strong second-quarter financial results, including significant organic orders growth and increased adjusted EPS, leading to a raised full-year earnings and profitability outlook.
Key Events · Earnings and Guidance · XYL
-
Strong Q2 Financial Performance
Xylem reported Q2 2026 revenue of $2.3 billion (up 1% organically) and adjusted earnings per share of $1.46 (up 16%), driven by strong execution.
-
Robust Organic Orders Growth
The company saw a significant 41% organic increase in orders, reaching $3.1 billion for the second quarter, indicating strong demand.
-
Raised Full-Year EPS Guidance
Xylem increased its full-year 2026 adjusted EPS guidance to a range of $5.55 to $5.70, up from the previous range of $5.35 to $5.60.
-
Increased Full-Year Profitability Outlook
The full-year 2026 adjusted EBITDA margin is now expected to be approximately 23.1% to 23.5%, an increase of 90 to 130 basis points from 2025 adjusted results.
Analysis · XYL · Technology
Xylem Inc. delivered robust second-quarter results, highlighted by a significant 41% organic growth in orders and a 16% increase in adjusted earnings per share. The company also raised its full-year adjusted EPS guidance to $5.55-$5.70 (from $5.35-$5.60) and increased its adjusted EBITDA margin outlook to 23.1-23.5%. While full-year revenue guidance was slightly tightened, the improved profitability outlook indicates strong operational execution and a positive trajectory for the company's earnings power.
At the time of this filing, XYL was trading at $122.15 on NYSE in the Technology sector, with a market capitalization of approximately $28.6B. The 52-week trading range was $105.29 to $154.27. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.